Omeros’ MASP-2 Antibody Preserves Brain Tissue and Function in Stroke Models
Fresh News,
— Data Published in Journal of Neuroinflammation — SEATTLE — (BUSINESS WIRE) — Omeros Corporation (NASDAQ: OMER) today…
— Data Published in Journal of Neuroinflammation — SEATTLE — (BUSINESS WIRE) — Omeros Corporation (NASDAQ: OMER) today…
] Omeros Corporation (NASDAQ: OMER) today announced results from its OMS721 complement program.
SEATTLE--(BUSINESS WIRE)-- Omeros Corporation ( OMER ) today announced results from its OMS721 complement program.
-- Data Published in Journal of Neuroinflammation -- Omeros Corporation (NASDAQ: OMER) today announced results from its OMS721…